logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (iv) All outpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids1.99.633.751.058.862.965.362.11759831910
Cocaine1.45.613.917.819.119.017.215.6570153662
Stimulants2.35.06.65.14.13.22.82.81590775
Hypnotics and sedatives1.21.11.41.31.61.82.66.47340157
Hallucinogens0.40.60.70.40.20.20.20.212961
Volatile substances4.90.70.10.10.10.10.10.17796
Cannabis 85.976.142.123.114.911.510.39.6976921326
Other substances 2.11.41.51.21.11.31.53.254945
Total4034394035981970880647425130837058342623615067142
 

Notes:

All countries included excluding Lithuania.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-103 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Monday, 09 July 2012